Intraperitoneal Chemotherapy Clinical Trial
Official title:
Use of a Heating Cable to Obtain Hyperthermia During Intraperitoneal Chemotherapy
The investigator will study the possibility of in situ heating of the liquid containing the
chemotherapy, so as to avoid the need for an external pumping system with its complexity,
and its associated risks and costs.
The use of a heating cable (prototype hereinafter called Thermowire, made by the company
EFS, which is in charge of its development) was patented and tested in pigs in two studies
that included 15 animals altogether (in 7 of which the heating cable was used). The aim of
the first study was the purely safety aspects, while the efficacy to obtain hyperthermia,
the quality and the homogeneity of the hyperthermia and its effect on the tissue penetration
of the chemotherapy were evaluated in a second study. The results obtained justify transfer
to use in humans in the context of a clinical trial so as to obtain CE certification.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04282356 -
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
|
Phase 2 |